EyePoint Pharmaceuticals
EYPT
#5922
Rank
C$1.68 B
Marketcap
C$20.09
Share price
3.29%
Change (1 day)
56.90%
Change (1 year)

Earnings for EyePoint Pharmaceuticals (EYPT)

Earnings in 2025 (TTM): -C$0.33 Billion

According to EyePoint Pharmaceuticals 's latest financial reports the company's current earnings are C$31.37 Million. a decrease over its 2024 earnings that were of -C$0.21 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for EyePoint Pharmaceuticals from 2003 to 2025

Annual earnings

Year Earnings Change
2025 -C$0.33 Billion63.24%
2024 -C$0.21 Billion104.29%
2023 -C$98.9 Million-29.88%
2022 -C$0.15 Billion87.2%
2021 -C$75.34 Million38.58%
2020 -C$54.37 Million-24.56%
2019 -C$72.06 Million
2017 -C$32.87 Million22.59%
2016 -C$26.81 Million-8.02%
2015 -C$29.15 Million-296.09%
2014 C$14.86 M-174.02%
2013 -C$20.09 Million37.42%
2012 -C$14.62 Million-56.29%
2011 -C$33.43 Million-1062.38%
2010 C$3.47 M-250.43%
2009 -C$2.31 Million-89.5%
2008 -C$22 Million
2005 -C$13.57 Million56.99%
2004 -C$8.65 Million73.7%
2003 -C$4.98 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Nymox Pharmaceutical
NYMX
-C$3.08 Million-99.07% Bahamas
NRC Health
NRC
C$39.25 M-111.90%๐Ÿ‡บ๐Ÿ‡ธ USA